期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ENDOCRINE-RELATED CANCER LetPub Score 7.4
50 ratings
Rate
Reputation 8.8 Influence 6.5 Speed 7.0 | ||||||||||||||||||||||||||||
期刊簡稱 | ENDOCR-RELAT CANCER | ||||||||||||||||||||||||||||
ISSN | 1351-0088 | ||||||||||||||||||||||||||||
E-ISSN | 1479-6821 | ||||||||||||||||||||||||||||
h-index | 119 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 2.40%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://erc.endocrinology-journals.org/ | ||||||||||||||||||||||||||||
在線稿件提交 | http://www.endocrinology-journals.org/site/misc/submit-online.xhtml | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | BioScientifica Ltd. | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||||||
創刊年 | 1994 | ||||||||||||||||||||||||||||
每年文章數 | 115每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 17.48% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1351-0088%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Ordinary | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[ENDOCRINE-RELATED CANCER] 的評論 | 撰寫評論 |
作者: 宁蒙氏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-07 22:04:03 評論於 There is no specific editor in mind.(0) 讚! | 宁蒙氏 |
作者: 云来俊贤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-05 15:06:27 評論於 Could you please tell me if the SchoolOne system will display the ADM's name? Mine only shows "under review" but does not display any editing options.(0) 讚! | 云来俊贤 |
作者: 宁蒙氏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-21 18:14:29 評論於 Research focus: Thyroid tumors Experience sharing: Submitted one article, reviewed by two reviewers, review process took about 3 months, accepted within 1 month after revisions. Editors and reviewers are responsible, emails inquiries are all responded to. The overall process takes about 4-5 months, urgent submissions may be temporarily suspended. The annual submission volume is small, OA mode is now available, pound sterling is the most cost-effective, about 28,000 RMB, receive first proof within 1 month, published in the 2nd or 3rd issue after acceptance(0) 讚! | 宁蒙氏 |
作者: 拂柳孟州 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-09 23:13:36 評論於 Review speed: 2.0 | Submission acceptance rate: 75.0 Focus research areas: Bioinformatics Experience sharing: None(0) 讚! | 拂柳孟州 |
作者: 北斗冰双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-18 12:03:06 評論於 Excuse me, does this magazine accept articles on bioinformatics and experiments? Do I need to provide original data and Western blotting membranes?(0) 讚! | 北斗冰双 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:45:54 評論於 1. Theme: Submission Section, Article Title, Published Pen Name. Content: The full content of the article. 2. Author information is included after the main text. Author information includes: your real contact address, postal code, name, email address, landline phone, cell phone, QQ number (with QQ name specified), and any other necessary contact information (such as a brief bio(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:18:41 評論於 After the reviewer completes the scoring of the chapter, they need to write a complete review opinion. This usually includes a brief summary of the content of the article, evaluation of the innovative points of the article, pointing out the shortcomings of the article, and giving advice on how the editor should handle the article(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 13:59:32 評論於 What aspects should be paid attention to in the letters sent by journals?(0) 讚! | 深渊兴业 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 20:04:05 評論於 What are the opinions and suggestions of journal editors? What are the opinions and suggestions of reviewers? What are the differences between the two?(0) 讚! | 八坂篷蔚 |
作者: 仲夏颖初 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-11 10:43:32 評論於 Review speed: 2.0 | Submission acceptance rate: 25.0 Experience sharing: ENDOCR-RELAT CANCER is a top journal in the field of endocrinology and metabolism, with high submission difficulty and quality articles(0) 讚! | 仲夏颖初 |
作者: 华美小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-02-07 09:11:47 評論於 I also rejected it in seconds, maybe not friendly to Chinese people(0) 讚! | 华美小可爱 |
作者: 魔都惜香 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-06 12:59:35 評論於 Can you give me some advice? Why am I being rejected so quickly?(0) 讚! | 魔都惜香 |
作者: 新荣mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-17 16:16:21 評論於 Try the feeling of wanting to be instantly rejected here for a few seconds haha(0) 讚! | 新荣mio |
作者: 四风文雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-05-06 08:01:26 評論於 Submission Hit Rate: 5.0. Sharing experience: If you want to experience the feeling of being instantly rejected, try submitting here, O(∩_∩)O haha~(0) 讚! | 四风文雅 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-16 10:09:28 評論於 Passing the 5-point mark is a cause for celebration. To reach the next level next year with 6 points would be even more remarkable(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-08-29 18:46:20 評論於 Review speed: 3.0 | Submission acceptance rate: 25.0 Experience sharing: Just submitted a paper to a top journal in the field, with the latest IF value rising to 5.261! The journal focuses on rigorous basic research. If you have a strong design and a complete story, it is worth submitting!(0) 讚! | 凌霄高洁 |
作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2013-04-02 10:12:00 評論於 This journal is published or managed by the Society for Endocrinology. Be careful with the scope of the papers it accepts. (1) 讚! | 匿名 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us